SARS-CoV-2 Vaccine Safety and Autoimmune Response-Reference-Cited by-同舟云学术

SARS-CoV-2 Vaccine Safety and Autoimmune Response

Published:2024-03-20 Issue:3 Volume:12 Page:334
ISSN:2076-393X
Container-title:Vaccines
language:en
Short-container-title:Vaccines

Author:

Tyan Yu-Chang¹²³⁴⁵^ORCID,Chuang Shih-Chang⁶,Ho Tzu-Chuan¹,Chuang Kuo-Pin³,Yang Ming-Hui⁶^ORCID

Affiliation:

1. Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung 807, Taiwan

2. Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan

3. Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung 912, Taiwan

4. Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan

5. Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan

6. Division of General & Digestive Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan

Abstract

Coronavirus disease 2019 (COVID-19) is a global public health crisis [...]

Funder

National Science and Technology Council

Kaohsiung Medical University

NPUST-KMU JOINT RESEARCH PROJECT

Research Center for Precision Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Publisher

MDPI AG

Link

https://www.mdpi.com/2076-393X/12/3/334/pdf

Reference22 articles.

1. Safety of COVID-19 vaccines administered in the EU: Should we be concerned?;Calina;Toxicol. Rep.,2021

2. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination;Scully;N. Engl. J. Med.,2021

3. Zhang, Y., Bissola, A.L., Treverton, J., Hack, M., Lychacz, M., Kwok, S., Arnold, A., and Nazy, I. (2024). Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders. J. Clin. Med., 13.

4. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2;Thiele;Blood,2021

5. Ho, T.-C., Chen, Y.-M.A., Chan, H.-P., Chang, C.-C., Chuang, K.-P., Lee, C.-H., Yuan, C.-H., Tyan, Y.-C., and Yang, M.-H. (2021). The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2. Vaccines, 9.